KNSA Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Product Growth RenovoRx Q1 2026 Earnings WiderthanExpected Loss as ClinicalStage Biotech Advances Pipeline FITBP Q1 2026 Earnings EPS Surges Past Estimates by 3509 PHIO Q1 2026 Earnings EPS Misses Estimates as ResearchFocused Biotech Maintains Development Pace MAZE Q1 2026 Earnings EPS Surprises to the Upside Revenue Yet to Materialize Cheche Group Q4 2024 Earnings EPS Beats Estimates as Loss Narrows but Shares Slide